155 related articles for article (PubMed ID: 34793841)
1. A broad influenza virus inhibitor acting via IMP dehydrogenase and in synergism with ribavirin.
Vanderlinden E; Marchand A; Van Berwaer R; van Dam W; Arzel P; Klaassen H; Persoons L; Chaltin P; Naesens L
Antiviral Res; 2021 Dec; 196():105208. PubMed ID: 34793841
[TBL] [Abstract][Full Text] [Related]
2. A novel benzo-heterocyclic amine derivative N30 inhibits influenza virus replication by depression of Inosine-5'-Monophospate Dehydrogenase activity.
Hu J; Ma L; Wang H; Yan H; Zhang D; Li Z; Jiang J; Li Y
Virol J; 2017 Mar; 14(1):55. PubMed ID: 28298229
[TBL] [Abstract][Full Text] [Related]
3. Antivirally active ribavirin analogues--4,5-disubstituted 1,2,3-triazole nucleosides: biological evaluation against certain respiratory viruses and computational modelling.
Krajczyk A; Kulinska K; Kulinski T; Hurst BL; Day CW; Smee DF; Ostrowski T; Januszczyk P; Zeidler J
Antivir Chem Chemother; 2014 Jan; 23(4):161-71. PubMed ID: 23538746
[TBL] [Abstract][Full Text] [Related]
4. Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.
Vanderlinden E; Vrancken B; Van Houdt J; Rajwanshi VK; Gillemot S; Andrei G; Lemey P; Naesens L
Antimicrob Agents Chemother; 2016 Nov; 60(11):6679-6691. PubMed ID: 27572398
[TBL] [Abstract][Full Text] [Related]
5. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon.
Markland W; McQuaid TJ; Jain J; Kwong AD
Antimicrob Agents Chemother; 2000 Apr; 44(4):859-66. PubMed ID: 10722482
[TBL] [Abstract][Full Text] [Related]
6. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
[TBL] [Abstract][Full Text] [Related]
7. [Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].
Leneva IA; Fediakina IT; Eropkin MIu; Gudova NV; Romanovskaia AA; Danilenko DM; Vinogradova SM; Lepeshkin AIu; Shestopalov AM
Vopr Virusol; 2010; 55(3):19-27. PubMed ID: 20608077
[TBL] [Abstract][Full Text] [Related]
8. [In vitro and in vivo anti-influenza virus activity of ribavirin injection].
Gao RM; Li XQ; He WY; Jiang JD; Li YH
Yao Xue Xue Bao; 2010 Mar; 45(3):403-7. PubMed ID: 21351521
[TBL] [Abstract][Full Text] [Related]
9. Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro.
Nguyen JT; Hoopes JD; Le MH; Smee DF; Patick AK; Faix DJ; Blair PJ; de Jong MD; Prichard MN; Went GT
PLoS One; 2010 Feb; 5(2):e9332. PubMed ID: 20179772
[TBL] [Abstract][Full Text] [Related]
10. Germacrone inhibits early stages of influenza virus infection.
Liao Q; Qian Z; Liu R; An L; Chen X
Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
12. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
Ölschläger S; Neyts J; Günther S
Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
[TBL] [Abstract][Full Text] [Related]
13. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.
Eichelberger MC; Hassantoufighi A; Wu M; Li M
Virol J; 2008 Sep; 5():109. PubMed ID: 18822145
[TBL] [Abstract][Full Text] [Related]
14. The synthesis and antiviral activity of 4-fluoro-1-beta-D-ribofuranosyl-1H-pyrazole-3-carboxamide.
Storer R; Ashton CJ; Baxter AD; Hann MM; Marr CL; Mason AM; Mo CL; Myers PL; Noble SA; Penn CR; Weir NG; Woods JM; Coe PL
Nucleosides Nucleotides; 1999 Feb; 18(2):203-16. PubMed ID: 10067273
[TBL] [Abstract][Full Text] [Related]
15. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
[TBL] [Abstract][Full Text] [Related]
16. In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.
Borroto-Esoda K; Myrick F; Feng J; Jeffrey J; Furman P
Antimicrob Agents Chemother; 2004 Nov; 48(11):4387-94. PubMed ID: 15504868
[TBL] [Abstract][Full Text] [Related]
17. Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.
Gao L; Han J; Si J; Wang J; Wang H; Sun Y; Bi Y; Liu J; Cao L
Antiviral Res; 2017 Jul; 143():106-112. PubMed ID: 28232246
[TBL] [Abstract][Full Text] [Related]
18. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
Leyssen P; Balzarini J; De Clercq E; Neyts J
J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
[TBL] [Abstract][Full Text] [Related]
19. In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.
Sleeman K; Mishin VP; Deyde VM; Furuta Y; Klimov AI; Gubareva LV
Antimicrob Agents Chemother; 2010 Jun; 54(6):2517-24. PubMed ID: 20350949
[TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase.
Muratore G; Goracci L; Mercorelli B; Foeglein Á; Digard P; Cruciani G; Palù G; Loregian A
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6247-52. PubMed ID: 22474359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
